Clinical trial
Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and…
NCT00438256 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00438256 |
|---|---|
| Title | Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer |
| Official title | Phase I/II of Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Dana-Farber Cancer Institute National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Proton Beam Radiation, Capecitabine |
| Enrollment | 50 |
| Start date | Dec 1, 2007 |
| Primary completion | Dec 1, 2017 |
| Completion | Dec 1, 2017 |
| First posted | Feb 22, 2007 |
| Last update posted | Jan 23, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: